Clinical Wide-Field Retinal Image Deep Learning Classification of Exudative and Non-Exudative Age-Related Macular Degeneration

被引:10
|
作者
Tak, Nathaniel [1 ]
Reddy, Akshay J. [1 ]
Martel, Juliette [2 ]
Martel, James B. [1 ]
机构
[1] Calif Northstate Univ, Coll Med, Ophthalmol, Elk Grove, CA 95757 USA
[2] Calif Northstate Univ, Hlth Sci, Rancho Cordova, CA USA
关键词
artificial intelligence in medicine; macular degeneration; optos imaging; convolutional neural networks (cnn); computer-aided diagnosis; ARTIFICIAL-INTELLIGENCE; PREDICTION;
D O I
10.7759/cureus.17579
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Age-related macular degeneration (AMD) is a disease that currently affects approximately 196 million individuals and is projected to affect 288 million in 2040. As a result, better and earlier detection methods for this disease are needed in an effort to provide a higher quality of care. One way to achieve this is through the utilization of machine learning. A deep neural network, specifically a convoluted neural network (CNN) can be trained to differentiate between different types of AMD images given the proper training data. Methods: In this study, a CNN was trained on 420 Optos wide-field retinal images for 70 epochs in order to classify between exudative and non-exudative AMD. These images were obtained and labeled by ophthalmologists from the Martel Eye Clinic in Rancho Cordova, CA. Results: After completing the study, a model was created with 88% accuracy. Both the training and validation loss started above 1 and ended below 0.2. Despite only analyzing a single image at a time, the model was still able to accurately identify if the individual had AMD in both eyes or one eye only. The model had the most trouble with bilateral non-exudative AMD. Overall the model was fairly accurate in the other categories. It was noted that the neural network was able to further differentiate from a single image if the disease is present in left, right, or both eyes. This is a point of contention for further investigation as it is impossible for the artificial intelligence (AI) to extrapolate the condition of both eyes from only one image. Conclusion: This research fostered the development of a CNN that was able to differentiate between exudative and non-exudative AMD. As well as determine if the disease is present in the right, left, or both eyes with a relatively high degree of accuracy. The model was trained on clinical data and can theoretically be used to classify other clinical images it has never encountered before.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Pegaptanib in exudative age-related macular degeneration
    Amoaku, WM
    DRUGS, 2005, 65 (11) : 1579 - 1579
  • [42] AMPK REGULATES MACULAR RETINAL PIGMENT EPITHELIUM MITOCHONDRIAL HOMEOSTASIS: ROLE IN EARLY NON-EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN MICE
    Dorfman, Damian
    Romeo, Horacio E.
    Alaimo, Agustina
    Bernal, Nathaly
    Calanni, Juan Salvador
    Sciurano, Roberta
    Rosenstein, Ruth Estela
    Dieguez, Hernan H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [43] Exudative non-neovascular age-related macular degeneration
    Tommaso Bacci
    Juliet O. Essilfie
    Belinda C. S. Leong
    K. Bailey Freund
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 1123 - 1134
  • [44] RESVEGA in exudative age-related macular degeneration
    Kubicz, A.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [45] Retinal thickness mapping in exudative age-related macular degeneration.
    Shakoor, A
    Zelkha, R
    Blair, NP
    Gieser, JP
    Shahidi, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U934 - U934
  • [46] Prevalence and clinical findings of retinal angiomatous proliferation in exudative age-related macular degeneration
    Conti, SM
    Patel, VR
    Chen, JC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U72 - U72
  • [47] Prophylactic Ranibizumab for Exudative age-related macular degeneration (AMD) in Vulnerable Eyes with Non-Exudative AMD Trial (PREVENT): A prospective controlled clinical trial
    Lalezary, Maziar
    Lin, Steven G.
    Chan, Clement K.
    Alok, Bansal S.
    Khurana, Rahul N.
    Wieland, Mark
    Chang, Louis K.
    Palmer, James
    Abraham, Prema
    Elman, Michael J.
    Lujan, Brandon J.
    Yiu, Glenn
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [48] Racial and Ethnic Differences in the Risk for Non-Exudative and Exudative Age-Related Macular Degeneration Among Asian Americans Compared With Other Races
    VanderBeek, B. L.
    Zacks, D. N.
    Talwar, N.
    Nan, B.
    Musch, D. C.
    Stein, J. D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [49] Machine Learning Identifies Predictors of Foveal Involvement in Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
    Cicinelli, Maria Vittoria
    Barlocci, Eugenio
    Giuffre, Chiara
    Rissotto, Federico
    Montesano, Giovanni
    Introini, Ugo
    Bandello, Francesco
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [50] Designing a Clinical Study to Evaluate Potential Therapeutics for Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
    Yates, Paul Andrew
    Holbrook, Kristina
    Reichel, Elias
    Waheed, Nadia K.
    Patrie, James
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)